Spironolactone hyperkalaemia — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Check potassium and renal function promptly and query suitability before supply
Spironolactone can cause hyperkalaemia, particularly when combined with ACE inhibitors. A potassium of 5.4 mmol/L warrants caution and prescriber discussion before starting or continuing treatment. Renal function should also be reviewed.
Reference: BNF; NICE CKS